Clarke Barlow

Mr Barlow is a Financial Adviser with 22 years of experience in the Financial Services Industry in Australia and the United Kingdom (UK). Mr Barlow has experience in structuring, operations and risk management of institutional exotic derivatives in the UK and has been responsible for establishing and managing derivatives trading desks for Australian based investment banks. Since 2007 Mr Barlow has serviced retail and institutional clients advising on share portfolios, derivatives, and identification of early-stage opportunities across a variety of industries and sectors. He also provides corporate advisory services for ASX listed companies across a variety of industries, with a focus on growth opportunities, providing them with advice on business models & strategy, structuring of pre-IPO and IPO fund raisings, reverse takeovers, capital raisings, M&A, investor relations and capital markets advice. Mr Barlow is a Founder and Director of AMG Acquisition Corp, a publicly listed company on the Toronto Venture Exchange (TSXV).

Companies and Roles

Company
Title
Tenure
Since
EX1
Exopharm Limited
  • Non-Executive Director
1yrsFeb 2023
NSB
NeuroScientific Biopharmaceuticals Ltd
  • Non-Executive Director
3mthNov 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
EX1
Exopharm Limited
01/12/2320,000N/A10,000,000N/A
NSB
NeuroScientific Biopharmaceuticals Ltd
17/11/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
EX1
Exopharm Limited
01/12/23
Issued
10,000,000$0.011$110,000Issue of options
EX1
Exopharm Limited
28/04/23
Issued
10,000$0.010$100Rights issue